These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Ventricular function in mitral valve prolapse: effects of beta adrenergic blockers with and without intrinsic sympathomimetic activity]. Marin-Neto JA; Mattar Júnior L; Maciel BC; Gallo Júnior L; Iazigi N; Ferro D Arq Bras Cardiol; 1989 May; 52(5):247-52. PubMed ID: 2690783 [TBL] [Abstract][Full Text] [Related]
3. Mitral valve prolapse syndrome: a six-month follow-up study of propranolol therapy. Hamilton CA; Nwangwu PU; Rapoport J; Parkison S; Stohs SJ Nebr Med J; 1979 Oct; 64(10):301-5. PubMed ID: 503256 [No Abstract] [Full Text] [Related]
4. [Propranolol versus placebo in long-term treatment of patients with mitral valve prolapse (author's transl)]. Erbel R; Schweizer P; Merx W; Effert S Z Kardiol; 1978 Nov; 67(11):729-35. PubMed ID: 726552 [No Abstract] [Full Text] [Related]
5. Beta-adrenergic antagonists in the treatment of patients with heart disease. Moses JW; Borer JS Dis Mon; 1981 Jun; 27(9):1-61. PubMed ID: 6114824 [No Abstract] [Full Text] [Related]
6. Attenuation of the circadian ST depression with propranolol in mitral valve prolapse. Abinader EG; Sharif D; Goldhammer E Am J Cardiol; 1994 May; 73(12):914-6. PubMed ID: 8184825 [No Abstract] [Full Text] [Related]
10. Prolapsed mitral valve syndrome. Kohn RM N Y State J Med; 1979 Feb; 79(2):238. PubMed ID: 285354 [No Abstract] [Full Text] [Related]
11. Heart rate and blood pressure in mitral valve prolapse patients: divergent effects of long-term propranolol therapy and correlations with catecholamines. da Silva EP; Pedro MM; Varela MG; Cortez-Dias N; Bicho MP; Madeira HC; Lopes MG Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():107-9. PubMed ID: 17584698 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of propranolol versus placebo in long-term treatment in patients with mitral valve prolapse. Erbel R; Wagner G; Schweizer P; Schäfer M; Merx W; Mutschler E; Effert S Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):457-63. PubMed ID: 389839 [TBL] [Abstract][Full Text] [Related]
14. Impact of echocardiography on antibiotic prophylaxis with suspected mitral valve prolapse. Cheng TO Am J Med; 1998 May; 104(5):509-10. PubMed ID: 9626042 [No Abstract] [Full Text] [Related]
15. Management of ventricular arrhythmias associated with mitral valve prolapse by combined alpha and beta blockade. Butrous GS; Maltz MB; O'Keefe J; Banim SO; Camm AJ Postgrad Med J; 1986 Apr; 62(726):259-63. PubMed ID: 3714619 [TBL] [Abstract][Full Text] [Related]
16. Response of ventricular arrhythmias to propranolol in mitral valve prolapse. Johnson MS Ala Med; 1988 Sep; 58(3):14-6. PubMed ID: 3177162 [No Abstract] [Full Text] [Related]
17. Normal coronary flow reserve in patients with mitral valve prolapse, a positive exercise test and normal coronary arteries. Tentolouris C; Petropoulakis P; Kyriakidis M; Karas S; Triposkiadis F; Gialafos J; Toutouzas P Eur Heart J; 1995 Dec; 16(12):1960-7. PubMed ID: 8682033 [TBL] [Abstract][Full Text] [Related]
18. Raynaud's disease in patients with mitral valvular prolapse. Meyer FH; Richter MA; Glancy DL; Akman D; Mahajan R J La State Med Soc; 1983 May; 135(5):16-7, 19. PubMed ID: 6553067 [No Abstract] [Full Text] [Related]